Chargement en cours...

Lamellar macular hole after intravitreal ocriplasmin injection

Intravitreal ocriplasmin was recently approved by the Food and Drug Administration to achieve medical vitreolysis in the setting of vitreomacular adhesion (VMA). We report a case of a 76-year-old woman who developed a lamellar macular hole following treatment with intravitreal ocriplasmin injection...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMJ Case Rep
Auteurs principaux: Chod, Ross Bronson, Goodrich, Clifford, Saxena, Sandeep, Akduman, Levent
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289753/
https://ncbi.nlm.nih.gov/pubmed/25576512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2014-207810
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!